2014 MPN study by Gilead and Evidera
September 18, 2014
Gilead Sciences, Inc is sponsoring a qualitative research study to evaluate the Modified Myeloproliferative Neoplasms Symptom Assessment Form Total Symptom Score (MPN-SAF TSS) in an electronic format. The study is being conducted by Evidera, Inc., on Gilead’s behalf, and involves the recruitment of up to 25 participants with myelofibrosis.Researchers are currently seeking participants for this study about experience with MPN symptoms. Criteria:
- Do you experience symptoms of MPN?
- Are you between the ages of 18 and 70?
- Are you willing to be interviewed about your experience with MPN?
- Are you willing to come to this clinic to meet with an interviewer or do an interview over the telephone?
If so, you may be eligible to participate in this study. Participants may receive compensation for their time and travel expenses. The study meeting will take approximately 2 hours of your time. For more information about this study, please call 1-800-762-8138 and ask for Preeti Dhillon.